DRKS00027499RecruitingNot Applicable
Testing of a new test system for diagnosis and therapy planning of severe blistering autoimmune diseases of the skin - FullSkin
niversitätsklinikum der RWTH Aachen0 sites40 target enrollmentStarted: February 24, 2022Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 40
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 Years to one (—)
- Sex
- All
Inclusion Criteria
- •All adult male and female patients can participate in this research project,
- •- who are suspected of having a blistering autoimmune skin disease.
- •- understand the nature, significance and scope of the research project
- •- are able to understand and follow the instructions of the study personnel
- •- who have signed an informed consent form
Exclusion Criteria
- •If one of the following criteria applies to the patient, he or she cannot participate in the research project
- •- Minority
- •- Pregnancy and breastfeeding
- •- lack of informed consent
- •- are incapable of giving consent and/or are unable to understand the nature, significance and scope of the research project and to give their consent in writing.
Investigators
Similar Trials
Active, not recruiting
Unknown
Evaluating a novel diagnostic test for the detection of Plasmodium infections at community level in The Gambia and Burkina FasoDiagnosis of Plasmodium infectionInfections and InfestationsISRCTN15263932MRC Unit The Gambia at LSHTM1,900
Recruiting
Not Applicable
COVID-19 ANTibody And T-cell AssaysACTRN12621000996864niversity of Otago3,000
Recruiting
Not Applicable
Development of non-invasive diagnostic test based on fetal DNA isolated from maternal blood (NATERA-study)chromosomal aberriationsgenetic defect10083624NL-OMON37477eids Universitair Medisch Centrum300
Active, not recruiting
Phase 1
Validation of a test system for development of medications for alcoholismEUCTR2015-002831-16-DETechnische Universität Dresden
Recruiting
Not Applicable
A study to determine the ability of a blood test for B-type Natriuretic Peptide signal peptide (BNP-SP) to act as an early indicator in Acute Coronary Syndrome (ACS)).Acute Coronary SyndromeACTRN12609000057280Health Research Council of New Zealand2,000